Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations

Allovir's CEO, Diana Brainard, sold shares of common stock on November 5, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On November 5, 2024, Diana Brainard, the CEO of Allovir, Inc. (ALVR), sold 10,609 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $0.8649, with individual transactions ranging from $0.856 to $0.9151.
• Following the transaction, Brainard directly owns 732,069 shares of Allovir common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect the CEO's view of the company's prospects.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for them to sell a portion of their shares to cover the taxes associated with the vesting of those shares. It does not necessarily indicate a lack of confidence in the company.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The percentage of shares sold for tax purposes is generally consistent with industry norms.
• Comparable companies such as Gilead, Amgen, and Regeneron often see similar transactions from their executives.

Stakeholder Impact

• The sale of shares could have a minor, temporary impact on the stock price.
• The transaction is unlikely to have a significant impact on employees, customers, suppliers, or creditors.

Key Dates